RESUMEN
OBJECTIVE: The COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid- and long- term impact of COVID-19 to cancer care in Asia. METHODS: The two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures. RESULTS: Participating stakeholders distilled five big questions. 1) "Will there be an explosion of late-stage cancers after the pandemic?" To address and recover from perceived delayed prevention, screening, treatment and care challenges, collaboration of key stakeholders in the region and alignment in cancer care management, policy intervention and cancer registry initiatives would be of essential value. 2) "Operations and Finance" The pandemic has resulted in significant material and financial casualties. Flagged acute challenges (shortages of supplies, imposition of lockdown) as well as longer-standing reduction of financial revenue, manpower, international collaboration, and training should also be addressed. 3) "Will telemedicine and technological innovations revolutionize cancer care?" Deploying and implementing telemedicine such as teleconsultation and virtual tumour boards were considered invaluable. These innovations could become a new regular practice, leading to expansion of tele-collaboration through collaboration of institutions in the region. 4) "Will virtual conferences continue after the pandemic?" Virtual conferences during the pandemic have opened new doors for knowledge sharing, especially for representatives of low- and middle-income countries in the region, while saving time and costs of travel. 5) "How do we prepare for the next pandemic or international emergency?" Roadmaps for action to improve access to appropriate patient care and research were identified and scrutinised. CONCLUSION: Through addressing these five big questions, focused collaboration among members and with international organisations such as City Cancer Challenge will allow enhanced preparedness for future international emergencies.
.
Asunto(s)
COVID-19 , Instituciones Oncológicas/organización & administración , Neoplasias/epidemiología , Telemedicina , Asia/epidemiología , Instituciones Oncológicas/economía , Control de Enfermedades Transmisibles , Congresos como Asunto , Diagnóstico Tardío , Atención a la Salud , Humanos , Neoplasias/diagnóstico , Neoplasias/patología , Neoplasias/terapia , SARS-CoV-2 , Comunicación por VideoconferenciaRESUMEN
In Nepal, while no population based cancer registry program exists to assess the incidence, prevalence, morbidity and mortality of cancer, at the national level a number of hospital based cancer registries are cooperating to provide relevant data. Seven major cancer diagnosis and treatment hospitals are involved, including the BP Koirala Memorial Cancer hospital, supported by WHO-Nepal since 2003. The present retrospective analysis of cancer patients of all age groups was conducted to assess the frequencies of different types of cancer presenting from January 1st to December 31st 2012. A total of 7,212 cancer cases were registered, the mean age of the patients being 51.9 years. The most prevalent age group in males was 60-64 yrs (13.6%), while in females it was 50-54 yrs (12.8%). The commonest forms of cancer in males were bronchus and lung (17.6%) followed by stomach (7.3%), larynx (5.2%) and non Hodgkins lymphoma (4.5%). In females, cervix uteri (19.1%) and breast (16.3%), were the top ranking cancer sites followed by bronchus and lung (10.2%), ovary (6.1%) and stomach (3.8%). The present data provide an update of the cancer burden in Nepal and highlight the relatively young age of breast and cervical cancer patients.
Asunto(s)
Instituciones Oncológicas , Neoplasias/epidemiología , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Nepal/epidemiología , Pronóstico , Sistema de Registros , Estudios Retrospectivos , Factores de Tiempo , Carga Tumoral , Adulto JovenRESUMEN
Pakistan, India, Sri Lanka, Bangladesh, Nepal and Bhutan, with their total population of more than 1,500 million, make up the subcontinent of South Asia. Despite massive diversity across the region, there are sufficient similarities to warrant a collective approach to chronic disease control, including development of cancer control programs. Cancer is already a major problem and there are general similarities in the prevalence patterns. In males, oral and lung cancer are either number one or two, depending on the registry, with the exceptions of Quetta in the far north, Larkana and Chennai. Moderately high numbers of pharyngeal and/or laryngeal cancer are also consistently observed, with prostate cancer now becoming visible in the more developed cities. Breast and cervical cancer share first and second place except in Muslim Pakistan, where oral cancer generally follows breast. The ovary is often included in the five most prevalent types. Markedly increasing rates for breast cancer and distribution shifts in other cancers suggest that, despite improvement in cervical and oral rates, the overall burden will only become heavier over time, especially with increasing obesity and aging of what are still youthful populations. Coordination of activities within South Asia is a high priority for cancer control in the region.
Asunto(s)
Neoplasias/epidemiología , Asia/epidemiología , Femenino , Humanos , Incidencia , Masculino , Neoplasias/prevención & control , Sistema de RegistrosRESUMEN
While comprehensive cancer registration data are available for some locations in India and Pakistan, the situation regarding other countries in South Asia is less clear. Only one publication with cancer incidence data is available in the literature for Nepal, for one hospital in the Western provinces. The present study was conducted to assess burden across a greater proportion of country with data from 7 major hospitals where cancer is diagnosed and treated. Data from each were transferred to the BP Koirala Memorial Cancer Hospital in Bharatput, the National Cancer Center of Nepal, for compilation. Overall the most common site in males was the lung, followed by the oral cavity and stomach, while the first three in females were cervix uteri, breast and lung. Shifts in the the main cancers were noted with different ages, with leukemias and lymphomas in young individuals replaced by lung, oral and stomach in middle age and lung, stomach and larynx in the oldest category of males. In females the shift was to breast in young women, then cervix in middle age followed by lung in the very aged. There was also variation between hospitals, but this appeared largely due to the differences in the therapeutic modalities available in different institutions.